Can specific cannabis compound combinations kill glioblastoma cells?
Lab research found that specific fractions from a high-THC cannabis strain had significant cytotoxic activity against glioblastoma cells and glioma stem cells, inducing apoptosis and inhibiting migration, invasion, and colony formation.
Quick Facts
What This Study Found
Fractions F4 and F5 from a high-THC cannabis extract showed significant cytotoxic activity against multiple GBM cell lines and patient-derived glioma stem cells. A standardized mix of these fractions induced apoptosis, activated endoplasmic reticulum stress genes, inhibited cell migration and invasion, altered cell cytoskeletons, and inhibited colony formation in both 2D and 3D models.
Key Numbers
Fractions F4 and F5 from high-THC strain; activity against multiple GBM cell lines and patient-derived glioma stem cells; inhibited colony formation in 2D and 3D models
How They Did This
In vitro study using HPLC and GC/MS for chemical characterization. Cytotoxicity measured by XTT and LDH assays. Apoptosis and cell cycle by FACS. Cell migration by scratch assay, invasion by transwell assay. Tested on GBM cell lines and glioma stem cells from tumor specimens.
Why This Research Matters
Glioblastoma is the most lethal brain cancer with very limited treatment options. Identifying specific cannabis compound combinations that target multiple cancer cell behaviors (proliferation, migration, invasion) could eventually lead to new therapeutic approaches.
The Bigger Picture
Most cannabis-cancer research has focused on individual compounds like THC or CBD. This study suggests that specific combinations of cannabis compounds may be more effective than single molecules, highlighting the potential importance of the entourage effect in anti-cancer applications.
What This Study Doesn't Tell Us
Entirely in vitro; cells in a dish do not replicate the complexity of tumors in a living brain. Many compounds show anti-cancer effects in vitro but fail in clinical settings. No animal or human data.
Questions This Raises
- ?Would these fractions retain their anti-cancer activity in animal models?
- ?Can the active compounds cross the blood-brain barrier at therapeutic concentrations?
- ?How do these fractions compare to standard glioblastoma treatments?
Trust & Context
- Key Stat:
- Active against glioma stem cells
- Evidence Grade:
- In vitro study only. While results are consistent across multiple cell models, no animal or human data exists.
- Study Age:
- Published in 2021; pre-clinical cancer research requires years to reach clinical trials.
- Original Title:
- Specific Compositions of Cannabis sativa Compounds Have Cytotoxic Activity and Inhibit Motility and Colony Formation of Human Glioblastoma Cells In Vitro.
- Published In:
- Cancers, 13(7) (2021)
- Authors:
- Peeri, Hadar, Shalev, Nurit(3), Vinayaka, Ajjampura C(2), Nizar, Rephael, Kazimirsky, Gila, Namdar, Dvora, Anil, Seegehalli M, Belausov, Eduard, Brodie, Chaya, Koltai, Hinanit
- Database ID:
- RTHC-03423
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Could cannabis treat brain cancer?
This lab study found specific cannabis compound combinations killed glioblastoma cells and blocked their spread. However, many compounds work in lab dishes but fail in actual patients, so clinical relevance remains unknown.
Was it just THC or CBD?
The active fractions contained multiple cannabis compounds beyond just THC and CBD. The study suggests combinations of compounds may be more effective than any single molecule.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-03423APA
Peeri, Hadar; Shalev, Nurit; Vinayaka, Ajjampura C; Nizar, Rephael; Kazimirsky, Gila; Namdar, Dvora; Anil, Seegehalli M; Belausov, Eduard; Brodie, Chaya; Koltai, Hinanit. (2021). Specific Compositions of Cannabis sativa Compounds Have Cytotoxic Activity and Inhibit Motility and Colony Formation of Human Glioblastoma Cells In Vitro.. Cancers, 13(7). https://doi.org/10.3390/cancers13071720
MLA
Peeri, Hadar, et al. "Specific Compositions of Cannabis sativa Compounds Have Cytotoxic Activity and Inhibit Motility and Colony Formation of Human Glioblastoma Cells In Vitro.." Cancers, 2021. https://doi.org/10.3390/cancers13071720
RethinkTHC
RethinkTHC Research Database. "Specific Compositions of Cannabis sativa Compounds Have Cyto..." RTHC-03423. Retrieved from https://rethinkthc.com/research/peeri-2021-specific-compositions-of-cannabis
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.